OBN, UK and Eurasanté, France, are delighted to announce the launch of BioSeed™, a joint venture event devised to provide a unique platform for early-stage Life Sciences companies, Technology Transfer Offices (TTO) and Universities throughout Europe seeking equity investment from Angels, High-Net-Worth individuals, specialist Crowd-Funders, and PE / VC funders genuinely interested in Seed and Series ‘A’ funding.

BioSeed® is a one-day event in London on 14 November 2017 and will feature presentations and pitches by early-stage organisations and a series of pre-scheduled one-to-one meetings with potential investors.

BioSeed® is the result of a shared vision between OBN and Eurasanté; with both parties observing a lack of industry events that solely support the interaction of early-stage companies with appropriate investors at a European level.

Due to the support that we have received from EY and our Cornerstone Sponsor, Ipsen, we are able to offer some substantial reductions on the normal registration cost during September:

• 1st-15th September 2017 - £200.00 + VAT

• 18th-30th September 2017 - £250.00 + VAT

From 1st October until the event date the prices will be as follows (as on the website):

• OBN and Eurasanté members - £300.00 + VAT

• Non-members - £350.00 + VAT

BioSeed Flyer